FSC Issues Statement About Talent Testing Service's Announcement

FSC Issues Statement About Talent Testing Service's Announcement

LOS ANGELES — The Free Speech Coalition today released a statement in reaction to an announcement made today from Talent Testing Service, which said that it will enhance its Gold Standard Panel test going forward.

The FSC, which operates performer testing service PASS, said the following:

FSC-PASS was glad to hear that TTS has chosen to include a free antibody testing panel to their gold standard panel. FSC-PASS had previously evaluated this antibody test, but found it offered no additional risk reduction for performers, while increasing costs for performers by at least $15. PASS will not mandate the use of the test but sees no issue if TTS or other centers choose to add it to the panel, so long as it does not increase performer costs.

The test, which measures HIV antibodies rather than RNA, is far less sensitive at diagnosing a recent HIV infection — it can have a window period of up a month — compared to the test currently used, which can detect an infection in as few as seven days.

Our true concern with the addition of the antibody test is that it’s not being done for scientific purposes, but in response to false and fear-based rumors of performers with HIV secretly working in PASS. Additions to the testing protocol should be done in consultation with medical doctors and infectious disease specialists, and based on actual risk.

Once more: no performer with HIV is permitted to work within the PASS system, and we have not had a transmission of the virus on a PASS-compliant set since 2004.

While TTS is welcome to add the antibody test to their panel, we do disagree with their statement regarding the HIV prevention campaign U=U (undetectable = untransmittable).  

The National Institute of Health, the Centers for Disease Control, the California Department of Public Health and hundreds of others public health organizations, infectious disease experts and research studies have confirmed that a person in active treatment for HIV can not transmit the virus to another person — effectively zero risk. Anyone who is curious about the science, can read about it here.

Copyright © 2026 Adnet Media. All Rights Reserved. XBIZ is a trademark of Adnet Media.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.

More News

Anna Claire Clouds Leads Dorcel's 'Fusion'

Reigning XMAs Female Performer of the Year Anna Claire Clouds headlines the latest release from Dorcel, titled “Fusion.”

Elise London Makes Her Elegant Angel Debut

Elise London has made her debut for Elegant Angel in a new release titled “Raunchy Redhead Anal.”

X3 All-Stars Party Heats Up Hollywood Thursday Night

The X3 All-Stars Party, sponsored by Adult Time and Fleshlight, will take place Thursday, Jan. 15, in Hollywood as the official kickoff to X3 Expo.

Naughty America Launches AR Video Format

Naughty America has launched "Shows," a new AR video format, on its Real Girls Now platform.

Alexis James Makes Her Kink.com Debut

Alexis James has made her Kink.com debut alongside Vince Karter in "Three Hole Domination."

Eris Jolie, Leah Hayes Front Latest From TransAngels

Eris Jolie and Leah Hayes star with Baxxx in the latest release from TransAngels, titled “Varsity Vixens.”

Olivia Del Rio Returns to Dorcel for 'PL4Y Vol. 2'

Olivia Del Rio stars in the new Dorcel title “PL4Y Vol. 2.”

Eve Sweet Leads Dorcel's 'Couture No. 3'

Reigning Euro XMAs Female Performer of the Year Eve Sweet headlines the latest release from Dorcel, titled “Couture No. 3.”

AEBN Reveals Ariel Demure as Top Trans Star for 2025

AEBN has revealed its top 10 trans stars list for 2025, with reigning XMAs Trans Performer of the Year Ariel Demure landing atop the leaderboard.

Agatha Vega Returns to Dorcel for 'Agatha's Secrets'

2024 Euro XMAs Performer of the Year Agatha Vega stars in the new Dorcel title “Agatha’s Secrets.”

Show More